Marshall Wace’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-100
Closed -$12.8K – 3478
2026
Q2
$12.8K Buy
+100
New +$11.7K ﹤0.01% 3066
2025
Q4
– Sell
-518,200
Closed -$43.5M – 3276
2025
Q3
$43.5M Buy
518,200
+350,200
+208% +$28.8M 0.04% 363
2025
Q2
$13.3M Buy
+168,000
New +$13.4M 0.02% 733
2025
Q1
– Sell
-140,000
Closed -$13.9M – 2914
2024
Q4
$13.9M Buy
+140,000
New +$14.4M 0.02% 674
2021
Q4
– Sell
-71,000
Closed -$5.33M – 4146
2021
Q3
$5.33M Buy
+71,000
New +$5.4M 0.02% 901

Other funds holding MRK

Marshall Wace's MRK Position: Q3 2026 in Review

Marshall Wace opened a new position in Merck (MRK) in Q3 2026: 2,781,934 shares worth $404M. The stake represents 0.35% of the portfolio and ranks #35 among its holdings. This is a return to the name: Marshall Wace previously reported a position in MRK as recently as Q1 2026.

Marshall Wace first reported a position in MRK in Q2 2014 and has held it in 42 quarters since. The position peaked at $557M in Q1 2022. 3,967 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Marshall Wace held 2,781,934 shares of Merck worth $404M as of Q3 2026.
  • Merck was a new Marshall Wace position in Q3 2026.
  • Merck made up 0.35% of Marshall Wace's portfolio in Q3 2026, its #35 holding.
  • Marshall Wace first reported a position in Merck in Q2 2014 and has held it in 42 quarters since.
  • Marshall Wace's Merck position peaked at $557M in Q1 2022.
  • 3,967 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Marshall Wace's 13F filing for Q3 2026, filed 13 Nov 2026.